Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-049650

Chief Financial Officer bought 5,000 shares at $2.10 ($10,490)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2023-09-13 Purchase +5,000 $2.10 $10,490 573,946 D
Open-market purchases · 5,000 sh · avg $2.10 · $10,490
Loading xslF345X05/doc4.xml…